Urgent Call for Reform in the Treatment of Incarcerated Mothers and Their Babies

A new report calls for urgent reforms in England and Wales' criminal justice system to address the emotional trauma caused by separating incarcerated mothers from their babies. The study highlights systemic failures and advocates for community-based alternatives, trauma-informed care, and better support for both mothers and staff.
A recent report has ignited urgent calls for reform within England and Wales' criminal justice system, spotlighting the profound emotional impact on mothers incarcerated and separated from their children. The collaborative research, known as the Lost Mothers Project, is a partnership between the University of Hertfordshire, the charity Birth Companions, and women with lived experience of incarceration. It aimed to examine the systemic failures and emotional toll associated with the enforced separation of mothers and infants in prison.
Drawing on a comprehensive 12-month study involving interviews, observations, and insights from staff across five women's prisons, the report reveals the devastating consequences of current practices. It highlights that many mothers experience intense emotional pain and physical distress due to separation, often compounded by delays and inconsistencies in accessing Mother and Baby Units (MBUs). Between 2023 and 2024, only 50 out of 92 applications for MBU placement were successful, with decisions frequently delayed and lacking adequate representation of mothers’ needs.
The findings also point to systemic shortcomings such as delays in decision-making, absence of specialized staff training, and insufficient support for both mothers and prison staff. The emotional strain on professionals working with these mothers further exacerbates the challenges.
Dr. Laura Abbott, lead researcher and associate professor at the University of Hertfordshire, emphasizes the trauma inflicted by forced separation. She states that the current prison system is not a safe environment for pregnant women, mothers, or their infants, and urges a transformative approach. The report advocates for community-based alternatives to incarceration, trauma-informed care, comprehensive staff training, and inclusive decision-making that respects mothers’ rights.
Naomi Delap of Birth Companions underscores the lifelong impact maternal separation can have on both mother and child, affecting bonding, attachment, breastfeeding, and maternal mental health. She advocates for prioritizing the first 1,001 days of a child's life—fundamental for healthy development—by adopting a radically different approach to pregnancy and motherhood within the justice system.
The report concludes with practical recommendations for immediate implementation, aiming to reduce unnecessary separations, support maternal well-being, and improve outcomes for families affected by incarceration.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Basophil Activation Test Surpasses Standard Methods in Detecting Milk Allergy in Children
A new study reveals that the Basophil Activation Test (BAT) outperforms traditional allergy tests in accurately diagnosing cow's milk allergy in children, potentially reducing the need for invasive food challenges.
Impact of Spinal Cord Injuries on Bladder Control and Emerging Treatment Insights
Recent studies reveal molecular pathways involved in neurogenic bladder caused by spinal cord injuries and explore potential treatments using inosine to protect bladder tissue and improve patient outcomes.
Brain Imaging Shows Action-Based Brain Organization in Individuals Without Hands
New neuroimaging research reveals that the brain is organized around actions like tool use, rather than specific body parts, demonstrating remarkable neural plasticity even in individuals born without hands.
Innovative CAR-T Cell Therapy Shows Promise for Autoimmune Hemophilia Treatment
A groundbreaking case at Hannover Medical School demonstrates the successful use of CAR-T cell therapy to treat acquired hemophilia A, offering new hope for autoimmune blood disorders resistant to conventional treatments.



